Welcome Back
Join CoinTime
Sign in with email
Sign up with email
Check your inbox
iCardiac Technologies
About
iCardiac Technologies is a laboratory that develops cardiac safety biomarkers which provide assessments of drugs in development.
- 51 - 100
Highlights
Details
- Last Funding Type
- Series B
- Industries
- Biopharma,Biotechnology,Health Care,Life Science
- Founded date
- Jan 1, 2006
- Number Of Employee
- 51 - 100
- Operating Status
- Active
iCardiac Technologies, Inc. develops cardiac safety biomarkers. The company offers Dynamic QTbtbsm, a suite of ECG-based cardiac safety markers that delivers assessment of the cardiac safety profile of drugs in development. Its technology is used in cardiac clinical trials conducted by pharmaceutical, biotechnology, and medical device companies. The company’s services include scientific and medical consultation, study design, data and project management, ECG analysis, statistical reporting, data submission, and interface with the regulators. iCardiac Technologies, Inc. was founded in 2006 and is headquartered in Rochester, New York.
Funding Rounds
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 6, 2014 | Series Unknown | — | 1 | — | — | Detail |
| Nov 14, 2007 | Series B | — | 2 | — | — | Detail |
| Nov 8, 2006 | Series A | $4M | 1 |
Advantage Capital
|
— | Detail |
Investors
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Norwest Venture Partners
|
— | Series Unknown |
|
Advantage Capital
|
— | Series B |
Stonehenge Growth Capital
|
— | Series B |
